Industry News

Analytics – It’s The Journey Not The Destination That Matters

HealthEconomics.Com’s Top Five Stories Of The Week!

Ulcerative Colitis Drug Trio Receives Negative Draft Guidance

A Step-By-Step Guide To Phama Market Access In Germany

How Do You Decide Which Evidence To Include In Your Presentations?

ISPOR Is Looking For Nominations For Board Of Directors

What If You Only Had To Pay For A Medication If It Worked?

A New Market Access Modus Operandi For US Pharma – Are You Ready?

Is The QALY A Valid Measurement?

Don’t Miss The Nation’s Largest Specialty Pharmacy Conference – Register Today!

A Quick Recap Of ISPOR’s HTA Asian Roundtable

If We Could Look Into The Future – What Would Healthcare Look Like?

Will The Majority Of Future Drugs Meet Orphan Drug Criteria?

Health Care Cost, Quality and Outcomes: ISPOR Book Of Terms

How To Construct Reimbursement Submissions In The Absence Of Head-To-Head Clinical Data

Valuable Insights From Germany’s AMNOG – Is It Working?

Abstract Submission For ISPOR 20th Annual International Meeting Now Open!

ISPOR’s Introduction To Health Systems Of BRICS Countries

Updated HTA Decision Map: How Are New Products Faring With Authorities In Europe, Canada and More

Therapeutic And Diagnostic Device Outcomes Research

Biosimilars – They’re Coming – Are You Ready?

How Can Digital Resources Help With Formulary Decision Making?

How Much Do You Know About The Pharmaceutical Markets In China & Hong Kong?

Evolving Health Systems In Asia: Opportunities And Challenges For Industry

Formulary Decision Makers Show Great Interest In Patient Support Tools

Barred Sales Reps, Disgraced Researchers & Groundbreaking New Apps – What Else Was In The News Last Week?

The Why, What, And How Of Big Data From ISPOR

ISPOR Taxonomy Of Patient Registries: Classification, Characteristics And Terms

Looking For Innovative Approaches For Achieving Value-Based, Quality Care In Oncology

Meet Sovaldi’s New Sidekick – Harvoni


Stay Connected